EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $20,015 | -99.3% | 3,827 | -98.0% | 0.00% | -100.0% |
| Q3 2023 | $3,022,083 | -9.3% | 191,635 | +11.8% | 0.01% | 0.0% |
| Q2 2023 | $3,332,618 | -47.2% | 171,431 | -22.9% | 0.01% | -50.0% |
| Q1 2023 | $6,310,339 | +43.3% | 222,430 | +47.7% | 0.01% | +25.0% |
| Q4 2022 | $4,402,856 | +89.0% | 150,628 | +70.8% | 0.01% | +100.0% |
| Q3 2022 | $2,329,000 | -74.8% | 88,172 | -57.6% | 0.00% | -73.3% |
| Q2 2022 | $9,248,000 | -25.8% | 208,169 | -17.4% | 0.02% | -6.2% |
| Q1 2022 | $12,470,000 | -11.0% | 251,979 | -8.5% | 0.02% | 0.0% |
| Q4 2021 | $14,018,000 | – | 275,305 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |